| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443847 | European Journal of Cancer | 2014 | 7 Pages |
Abstract
Ipilimumab may be a feasible treatment option in pretreated patients with metastatic mucosal melanoma, and warrants further investigation in prospective clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michele Del Vecchio, Lorenza Di Guardo, Paolo A. Ascierto, Antonio M. Grimaldi, Vanna Chiarion Sileni, Jacopo Pigozzo, Virginia Ferraresi, Carmen Nuzzo, Gaetana Rinaldi, Alessandro Testori, Pier F. Ferrucci, Paolo Marchetti, Federica De Galitiis,